Global Spectral Computed Tomography Market

Spectral Computed Tomography Market Size, Share, Growth Analysis, By Product(Spiral CT, Electron Beam Tomography, Multi-slice Computed Tomography, Positron Emission Tomography (Pet) and Single-photon Emission Computed Tomography), By Application(Oncology, Neurology, Cardiology, Vascular and Others), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2794 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 65 | Figures: 77

Spectral Computed Tomography Market Regional Insights

In 2021 North America held a commanding position, accounting for 30.4 % of the market and with no one able to challenge over the forecast period. This was due to several factors, such as the concentration of market competitors in a relatively small area and an increase in cancer rates. According to the National Cancer Institute, 1,806,590 cancer sufferers were diagnosed in the U.S. alone during that same year (2020). Furthermore, the arrival of cutting-edge technology which incorporates elements from artificial intelligence as well as frequent launches for low radiation CT scans promise to spur even greater market growth.

Over the forecast period, a substantial CAGR would be achieved in all regions of Asia Pacific. The growth process is supported by the expanding healthcare environment, particularly in developing countries such as India and China. In addition, the high rate of penetration for advanced medical imaging equipment is also driving this expansion. Factors like the growing tendency to suffer from chronic diseases and the establishment of local manufacturers is expected only to accelerate market growth. For Instance, Siemens Healthineers recently set up a new facility for production of CT scanners in India to address the demand there and further expand its market position.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spectral Computed Tomography Market size was valued at USD 7.03 billion in 2022 and is poised to grow from USD 7.49 billion in 2023 to USD 12.39 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The market demonstrates a moderate level of consolidation, where a few major players hold a substantial portion of the revenue share. These key industry participants are strategically focused on introducing innovative products to solidify their positions in the market. 'Siemens Healthineers', 'GE Healthcare', 'Philips Healthcare', 'Toshiba Medical Systems Corporation', 'Hitachi Medical Corporation', 'Shimadzu Corporation', 'Carestream Health', 'Samsung Medison', 'Hologic, Inc.', 'Fujifilm Medical Systems', 'Esaote SpA', 'Agfa-Gevaert Group', 'Mindray Medical International Limited', 'Planmed', 'CurveBeam LLC', 'Medtronic plc', 'Konica Minolta, Inc.', 'Varian Medical Systems', 'Analogic Corporation', 'NeuroLogica Corporation', 'Xoran Technologies, LLC', 'Cubresa Inc.'

The Spectral Computed Tomography (CT) market is witnessing significant growth, driven by the promise of enhanced diagnostic accuracy. Spectral CT technology goes beyond conventional CT scanning by capturing data at different energy levels, allowing for a more detailed analysis of tissue composition and material characterization. This advancement enables healthcare professionals to obtain comprehensive insights into the underlying properties of tissues, leading to improved detection and characterization of various medical conditions. The ability to differentiate between different materials based on their spectral signatures enhances diagnostic precision, particularly in complex cases where traditional CT imaging may fall short. By providing a more nuanced understanding of tissue composition, Spectral CT contributes to early and accurate diagnoses, ultimately improving patient outcomes and paving the way for more personalized and effective medical interventions.

The Spectral CT market has seen unexpected advancements, predominantly in reducing radiation doses. This progress aligns with the increasing importance of patient safety and minimizing radiation exposure in medical imaging procedures. Spectral CT technology introduces novelties like dual-energy imaging, which enables better tissue characterization and visualization while substantially lowering the radiation dose required for scans. By utilizing different energy spectra, spectral CT optimizes imaging protocols to fold more information with summary radiation exposure, making it an invaluable advancement in diagnostic imaging, particularly for susceptible populations or individuals demanding recurrent scans.

In 2021 North America held a commanding position, accounting for 30.4 % of the market and with no one able to challenge over the forecast period. This was due to several factors, such as the concentration of market competitors in a relatively small area and an increase in cancer rates. According to the National Cancer Institute, 1,806,590 cancer sufferers were diagnosed in the U.S. alone during that same year (2020). Furthermore, the arrival of cutting-edge technology which incorporates elements from artificial intelligence as well as frequent launches for low radiation CT scans promise to spur even greater market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spectral Computed Tomography Market

Report ID: SQMIG35A2794

$5,300
BUY NOW GET FREE SAMPLE